Faconi Anemia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Clinical Trials

A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype A
Condition:   Fanconi Anemia Complementation Group A Intervention:   Biological: RP-L102 Sponsor:   Rocket Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2019 Category: Research Source Type: clinical trials

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
Conditions:   Hematologic Malignancies;   Nonmalignant Diseases;   Immunodeficiencies;   Hemoglobinopathies;   Genetic Inborn Errors of Metabolism;   Fanconi's Anemia;   Thalassemia;   Sickle Cell Disease Intervention:   Sponsor:   University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2018 Category: Research Source Type: clinical trials